Published in Vaccine Weekly, July 19th, 2006
"Expression of tumor antigen-specific chimeric receptors in T lymphocytes can redirect their effector functions towards tumor cells. Integration of the signaling domains of the costimulatory molecule CD28 into chRec enhances antigen-specific proliferation of polyclonal human T cell populations," scientists in Germany report.
According to B. Altvater and colleagues at the University of Munster, "While CD28 plays an essential role in the priming of naive CD4+ T cells, its contribution to effector...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.